Here, we demonstrate that the TGF‐β1/Smad3 signaling pathway plays a critical role in regulating microglial phagocytic ability in removing Aβ and p‐tau aggregates, and more importantly, in reversing cognitive deficits during the advanced stage of AD. The gene discussed is SMAD3; the disease is Cognitive impairment.